Toronto, Canada (PRWEB) April 05, 2013
Bringing a therapy to market can cost billions. Now with support from the FDA and EMA, the industry is ready to realize the promise of risk-based monitoring.
By integrating best practices from RBM studies with new approaches and innovative technology, Mr. Dan White, Vice-President of Global Operations at Quintiles, will share common challenges, lessons learned, and how to best apply processes and technology to deliver the optimal outcome for a study.
Specifically, this webinar will explore how to:
For more information about this event or to register, visit: http://xtks.in/xto576-event
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227
Read the full story at http://www.prweb.com/releases/2013/4/prweb10599131.htm.
Copyright©2012 Vocus, Inc.
All rights reserved